EPISODE · Jun 1, 2026 · 38 MIN
Inside the Tivic Health Journey with Jennifer Ernst
from The Open Loop · host Chay Carter
In this episode of The Open Loop, Chay Carter is joined by Jennifer Ernst, founder and former CEO of Tivic Health (now Valion Bio). Jennifer shares the story behind Tivic’s journey, from consumer bioelectronics and non-invasive stimulation to FDA clearance, retail launch, IPO, supply chain disruption, and a major pivot into biopharma. This is a practical conversation about the rollercoaster journey of building regulated consumer neurotechnology, bringing a new category to market, and navigating the strategic decisions founders face when timing, capital, and market conditions change. We also look ahead to the future of bioelectronic medicine, including peripheral nerve stimulation, AI-native company building, and how electrical and pharmaceutical approaches could eventually work together. Key takeaways: 🔹 Why “going consumer” is not always the easier route for neurotech companies🔹 What founders need to understand about category creation, claims, and customer acquisition🔹 How Tivic navigated FDA clearance, retail launch, IPO, and supply chain disruption🔹 Why remote monitoring, reimbursement, and physician incentives matter for device adoption🔹 How AI, peripheral nerve stimulation, and bioelectronic medicine could shape the next phase of neurotech Host:Chay CarterFounder, Carter SciencesCo-Founder, Reccy NeuroLinkedIn: https://www.linkedin.com/in/chay-carter/ Guest:Jennifer ErnstFounder and former CEO of Tivic Health (now Valion Bio)LinkedIn: https://www.linkedin.com/in/jenniferernst/ Key Chapters: 00:00 Introduction to Jennifer Ernst and Tivik Health03:28 The Journey into Bioelectronics and Neurotechnology07:01 Consumer Market Challenges in Neurotechnology10:02 Navigating the IPO Process and Supply Chain Issues14:01 Lessons Learned from the Tivik Experience17:39 The Future of Neurotechnology and AI Integration23:09 Vagus Nerve Stimulation and Its Potential28:51 Transitioning to Biopharmaceuticals and Future Directions The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology.
What this episode covers
In this episode of The Open Loop, Chay Carter is joined by Jennifer Ernst, founder and former CEO of Tivic Health (now Valion Bio). Jennifer shares the story behind Tivic’s journey, from consumer bioelectronics and non-invasive stimulation to FDA clearance, retail launch, IPO, supply chain disruption, and a major pivot into biopharma. This is a practical conversation about the rollercoaster journey of building regulated consumer neurotechnology, bringing a new category to market, and navigating the strategic decisions founders face when timing, capital, and market conditions change. We also look ahead to the future of bioelectronic medicine, including peripheral nerve stimulation, AI-native company building, and how electrical and pharmaceutical approaches could eventually work together. Key takeaways: 🔹 Why “going consumer” is not always the easier route for neurotech companies🔹 What founders need to understand about category creation, claims, and customer acquisition🔹 How Tivic navigated FDA clearance, retail launch, IPO, and supply chain disruption🔹 Why remote monitoring, reimbursement, and physician incentives matter for device adoption🔹 How AI, peripheral nerve stimulation, and bioelectronic medicine could shape the next phase of neurotech Host:Chay CarterFounder, Carter SciencesCo-Founder, Reccy NeuroLinkedIn: https://www.linkedin.com/in/chay-carter/ Guest:Jennifer ErnstFounder and former CEO of Tivic Health (now Valion Bio)LinkedIn: https://www.linkedin.com/in/jenniferernst/ Key Chapters: 00:00 Introduction to Jennifer Ernst and Tivik Health03:28 The Journey into Bioelectronics and Neurotechnology07:01 Consumer Market Challenges in Neurotechnology10:02 Navigating the IPO Process and Supply Chain Issues14:01 Lessons Learned from the Tivik Experience17:39 The Future of Neurotechnology and AI Integration23:09 Vagus Nerve Stimulation and Its Potential28:51 Transitioning to Biopharmaceuticals and Future Directions The Open Loop is a podcast exploring the people, companies, and ideas shaping the future of neurotechnology.
NOW PLAYING
Inside the Tivic Health Journey with Jennifer Ernst
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m